Thursday, January 12, 2017

Eye - Table of Contents alert Volume 31 Issue 1

If you are unable to see the message below, click here to view.
Eye

TABLE OF CONTENTS

Volume 31, Issue 1 (January 2017)

In this issue
Special Section On AMD
Reviews
Clinical Studies
Laboratory Studies
Case Series
Correspondence
Corrigendum

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Follow us on Twitter
Facebook

Special Section On AMD

Top

Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents

M Gemenetzi, A J Lotery and P J Patel

Eye 2017 31: 1-9; advance online publication, October 7, 2016; 10.1038/eye.2016.208

Abstract | Full Text

Structural and molecular changes in the aging choroid: implications for age-related macular degeneration

K R Chirco, E H Sohn, E M Stone, B A Tucker and R F Mullins

Eye 2017 31: 10-25; advance online publication, October 7, 2016; 10.1038/eye.2016.216

Abstract | Full Text

A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration

U Schmidt-Erfurth, S Klimscha, S M Waldstein and H Bogunović

Eye 2017 31: 26-44; advance online publication, November 25, 2016; 10.1038/eye.2016.227

Abstract | Full Text

Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy

K Takayama, Y Ito, H Kaneko, K Kataoka, T Sugita, R Maruko, K Hattori, E Ra, F Haga and H Terasaki

Eye 2017 31: 45-52; advance online publication, November 4, 2016; 10.1038/eye.2016.232

Abstract | Full Text

Impact of optical coherence tomography scanning density on quantitative analyses in neovascular age-related macular degeneration

S B Velaga, M G Nittala, R K Konduru, F Heussen, P A Keane and S R Sadda

Eye 2017 31: 53-61; advance online publication, December 2, 2016; 10.1038/eye.2016.260

Abstract | Full Text

The association of geographic atrophy and decreased renal function in patients with age-related macular degeneration

H B Leisy, A Rastogi, G Guevara, M Ahmad and R T Smith

Eye 2017 31: 62-67; advance online publication, November 11, 2016; 10.1038/eye.2016.261

Abstract | Full Text

Reviews

Top

The zebrafish eye—a paradigm for investigating human ocular genetics

R Richardson, D Tracey-White, A Webster and M Moosajee

Eye 2017 31: 68-86; advance online publication, September 9, 2016; 10.1038/eye.2016.198

Abstract | Full Text

Doyne lecture 2016: intraocular health and the many faces of inflammation

A D Dick

Eye 2017 31: 87-96; advance online publication, September 16, 2016; 10.1038/eye.2016.177

Abstract | Full Text

Clinical Studies

Top

Continuing Medical Education Safety and acceptability of an organic light-emitting diode sleep mask as a potential therapy for retinal disease

J N Sahni, G Czanner, T Gutu, S A Taylor, K M Bennett, S M Wuerger, I Grierson, C Murray-Dunning, M N Holland and S P Harding

Eye 2017 31: 97-106; advance online publication, December 16, 2016; 10.1038/eye.2016.259

Abstract | Full Text

Real world outcomes of ocriplasmin use by members of the British and Eire Association of Vitreoretinal Surgeons

R J Haynes, D Yorston, D A H Laidlaw, J Keller and D H W Steel

Eye 2017 31: 107-112; advance online publication, September 2, 2016; 10.1038/eye.2016.195

Abstract | Full Text

Ophthalmic presentation of giant cell arteritis in African-Americans

S T Garrity, M Pistilli, M S Vaphiades, N Q Richards, P S Subramanian, P R Rosa, B L Lam, B J Osborne, G T Liu, K E Duncan, R K Shin, N J Volpe, K S Shindler, M S Lee, M L Moster, E H Tracey, S E Cuprill-Nilson and M A Tamhankar

Eye 2017 31: 113-118; advance online publication, September 16, 2016; 10.1038/eye.2016.199

Abstract | Full Text

Developing new automated alternation flicker using optic disc photography for the detection of glaucoma progression

J Ahn, I S Yun, H G Yoo, J-J Choi and M Lee

Eye 2017 31: 119-126; advance online publication, September 23, 2016; 10.1038/eye.2016.204

Abstract | Full Text

Multicolor imaging in the diagnosis and follow up of type 2 acute macular neuroretinopathy

G De Salvo, S Vaz-Pereira, R Arora and A J Lotery

Eye 2017 31: 127-131; advance online publication, September 30, 2016; 10.1038/eye.2016.193

Abstract | Full Text

Outcomes of microcatheter-assisted trabeculotomy following failed angle surgeries in primary congenital glaucoma

Y Shi, H Wang, J Yin, X Zhang, M Li, C Xin, X Chen and N Wang

Eye 2017 31: 132-139; advance online publication, October 14, 2016; 10.1038/eye.2016.212

Abstract | Full Text

In vivo confocal microscopy of toxic keratopathy OPEN

Y Chen, Q Le, J Hong, L Gong and J Xu

Eye 2017 31: 140-147; advance online publication, October 14, 2016; 10.1038/eye.2016.213

Abstract | Full Text

Augmented vertical recti transposition with intraoperative botulinum toxin for complete and chronic sixth nerve palsy

R Nabie and D Andalib

Eye 2017 31: 148-151; advance online publication, November 4, 2016; 10.1038/eye.2016.226

Abstract | Full Text

Laboratory Studies

Top

Design and performance of a large lumen glaucoma drainage device

J L Olson and S Groman-Lupa

Eye 2017 31: 152-156; advance online publication, September 9, 2016; 10.1038/eye.2016.182

Abstract | Full Text

Case Series

Top

The use of transdermal optical coherence tomography to image the superficial temporal arteries

S P Mollan, P A Keane and A K Denniston

Eye 2017 31: 157-160; advance online publication, October 14, 2016; 10.1038/eye.2016.206

Abstract | Full Text

Correspondence

Top

Can photoreceptor loss also account for changes in pupil size following panretinal photocoagulation?

R P Najjar and D Milea

Eye 2017 31: 161; advance online publication, September 30, 2016; 10.1038/eye.2016.210

Full Text

Reply to ‘Can photoreceptor loss also account for changes in pupil size following panretinal photocoagulation?

I Yilmaz and A Ozkaya

Eye 2017 31: 161-162; advance online publication, October 7, 2016; 10.1038/eye.2016.211

Full Text

Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy

D Călugăru and M Călugăru

Eye 2017 31: 162; advance online publication, October 7, 2016; 10.1038/eye.2016.214

Full Text

Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy

F Ricci, M Parravano, F Regine, M Sciamanna, M Tedeschi, F Missiroli and M Varano

Eye 2017 31: 163-164; advance online publication, October 7, 2016; 10.1038/eye.2016.215

Full Text

Recent subspecialty trends in ophthalmology consultant appointments

O Bowes, W Dean and A D Borman

Eye 2017 31: 164-165; advance online publication, October 14, 2016; 10.1038/eye.2016.176

Full Text

Corrigendum

Top

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study

F G Holz, R Tadayoni, S Beatty, A R Berger, M G Cereda, P Hykin, G Staurenghi, K Wittrup-Jensen, J Nilsson, K Kim and S Sivaprasad

Eye 2017 31: 166; 10.1038/eye.2016.276

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Eye. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: